The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas)
Open accessAbstract
Neuroendocrine neoplasms (NEN) of the appendix are a relatively frequent subgroup of NEN with an approximate incidence rate of 0.15-0.6/100,000/year and with a slight female preponderance in Western series [1,2,3,4,5,6,7,8,9,10,11,12]. Although NEN are frequently reported [13], most cases are of an early stage [12,13,14]. The reported incidence has increased in more recent years [1,6]; however, the overall incidence rate is probably roughly within the same range between different races, although some differences have been reported [1,12,15,16,17,18]. Furthermore, common practice in performing appendicectomies may also influence the reported incidence of appendiceal NEN [19,20].Appendiceal NEN comprise the largest subgroup of appendiceal neoplasms with approximately 30-80% of all appendiceal neoplasms [1,13,14,21,22,23,24]. Mean age at diagnosis has been reported between 38 and 51 years [6,24,25,26]. However, appendiceal NEN have also been reported in pediatric patients between 4.5 and 19.5 years of age [2,4,17,27,28,29], but population-based data are not available for this special subgroup.The prognosis of the majority of appendiceal NEN is excellent in the series that report outcome on lower tumor stages with 5-year survival rates (YSR) of 100% or close to this [7,14,11,25,30,31,32]. However, the whole cohort including all tumor stages does not show such a favorable prognosis, with 5-YSR ranging between 70 and 85% [11,25,30,31,33]. Advanced stages with distant metastases have been reported with a much poorer prognosis and a 5-YSR of as low as 12-28% [1,11,14]. However, it is not clear to which extent more ‘malignant' histologies such as goblet cell carcinoids (GCC) or mixed adenoneuroendocrine carcinomas with a poorer prognosis per se were included in such series.Appendiceal NEN present with an incidence of 0.15-0.6/100,000/year. They are diagnosed slightly more often in female than in male patients at an average age of 40-50 years. Appendiceal NEN are, however, much more frequently diagnosed incidentally during appendicectomy with a rate of approximately 3-5/1,000 appendicectomies. Racial differences may occur but data are inconclusive. In contrast, malignant tumors seem to occur more often in Caucasians compared to other races. Appendiceal NEN may also rarely occur in children but apparently with an excellent long-term outcome. While at a lower stage, survival is extremely good (local disease: 5-YSR of 95-100%, regional disease: 5-YSR of 85-100%), on the other hand, the few cases with distant metastasis present with relatively poor survival figures (5-YSR: <25%).From the available data, it is concluded that an appendiceal NEN <1 cm, with invasion up to the subserosa or mesoappendiceal invasion up to 3 mm and clear surgical margins poses no further risk of recurrence after appendicectomy.Most tumors (70%) are located at the tip of the appendix. However, tumors at the base of the appendix, tumors of 1-2 cm in diameter and tumors with deep mesoappendiceal invasion or margin invasion confer a relevant risk of recurrence, and further surgical procedures are warranted, although no data have literally proven a survival benefit of more aggressive surgery.Most appendiceal NEN in adults as well as in children are incidental findings in postappendicectomy specimen and therefore no characteristic tumor-specific symptomatology has been established [5,17]. However, symptoms that lead to appendicectomy such as right lower abdominal pain are indirectly associated with appendiceal NEN, although due to their most frequent localization at the tip of the appendix (approx. 70%) these tumors are very likely not causative of acute appendicitis [34,35,36,37,38,39,40,41]. In the rare cases of distant metastases, these may cause symptoms related to the localization of the metastases.A carcinoid syndrome is an extreme exception in metastatic patients [35,36,38] and more likely associated with an intestinal primary tumor.Appendiceal NEN are rarely symptomatic in the large majority of cases due to the incidental nature of their diagnosis. However, tumors with extensive local disease or distant metastases may appear symptomatic with abdominal pain, a tumor mass effect or signs of bowel obstruction. An association with the carcinoid syndrome is extremely rare and indicates metastatic disease.Since most appendiceal NEN are incidentally diagnosed during postoperative histology, diagnostic procedures relate mostly to postoperative staging, follow-up and to the rare cases with suspected or evidenced distant metastasis.There are no specific diagnostic studies focusing on appendiceal NEN only, and therefore the considerations which apply to small intestinal NEN are considered to be also valid for appendiceal NEN and have not been changed since the previous version of the guidelines.Cross-sectional imaging using CT or MRI with modern protocols should be used to rule out locoregional or distant metastasis [42,43,44,45]. NEN limited to the app
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., Abdalla, E. K., Fleming, J. B., Vauthey, J.-N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4377 · Cited by 4,510
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
Falconi, M., Eriksson, B., Kaltsas, G., Bartsch, D. K., Capdevila, J., Caplin, M., Kos-Kudla, B., Kwekkeboom, D., Rindi, G., Klöppel, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000443171 · Cited by 1,362
Self-citationPavel, M., O''Toole, D., Costa, F., Capdevila, J., Gross, D., Kianmanesh, R., Krenning, E., Knigge, U., Salazar, R., Pape, U.-F., et al. (2016) · Neuroendocrinology · doi:10.1159/000443167 · Cited by 1,041
Self-citationRindi, G., Klöppel, G., Couvelard, A., Komminoth, P., Körner, M., Lopes, J. M., McNicol, A.-M., Nilsson, O., Perren, A., Scarpa, A., et al. (2007) · Virchows Archiv · doi:10.1007/s00428-007-0452-1 · Cited by 955
Self-citationGarcia-Carbonero, R., Sorbye, H., Baudin, E., Raymond, E., Wiedenmann, B., Niederle, B., Sedlackova, E., Toumpanakis, C., Anlauf, M., Cwikla, J. B., et al. (2016) · Neuroendocrinology · doi:10.1159/000443172 · Cited by 611
Self-citationMcCusker, M. E., Coté, T. R., Clegg, L. X., & Sobin, L. H. (2002) · Cancer · doi:10.1002/cncr.10589 · Cited by 610
Neuroendocrine tumor epidemiology: Contrasting Norway and North America
Hauso, O., Gustafsson, B. I., Kidd, M., Waldum, H. L., Drozdov, I., Chan, A. K. C., & Modlin, I. M. (2008) · Cancer · doi:10.1002/cncr.23883 · Cited by 505
ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
Delle Fave, G., O''Toole, D., Sundin, A., Taal, B., Ferolla, P., Ramage, J. K., Ferone, D., Ito, T., Weber, W., Zheng-Pei, Z., et al. (2016) · Neuroendocrinology · doi:10.1159/000443168 · Cited by 495
Self-citationENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
Niederle, B., Pape, U.-F., Costa, F., Gross, D., Kelestimur, F., Knigge, U., Öberg, K., Pavel, M., Perren, A., Toumpanakis, C., et al. (2016) · Neuroendocrinology · doi:10.1159/000443170 · Cited by 474
Self-citationPape, U.-F., Perren, A., Niederle, B., Gross, D., Gress, T., Costa, F., Arnold, R., Denecke, T., Plöckinger, U., Salazar, R., et al. (2012) · Neuroendocrinology · doi:10.1159/000335629 · Cited by 465
Self-citationNiederle, M. B., Hackl, M., Kaserer, K., & Niederle, B. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-10-0152 · Cited by 444
Self-citationCarcinoid Tumor of the Appendix: Treatment and Prognosis
Moertel, C. G., Weiland, L. H., Nagorney, D. M., & Dockerty, M. B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712313172704 · Cited by 427
Garcia-Carbonero, R., Capdevila, J., Crespo-Herrero, G., Díaz-Pérez, J. A., Martínez del Prado, M. P., Alonso Orduña, V., Sevilla-García, I., Villabona-Artero, C., Beguiristain-Gómez, A., Llanos-Muñoz, M., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq022 · Cited by 419
Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan
Ito, T., Sasano, H., Tanaka, M., Osamura, R. Y., Sasaki, I., Kimura, W., Takano, K., Obara, T., Ishibashi, M., Nakao, K., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-009-0194-8 · Cited by 394
Tang, L. H., Shia, J., Soslow, R. A., Dhall, D., Wong, W. D., O'Reilly, E., Qin, J., Paty, P., Weiser, M. R., Guillem, J., et al. (2008) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31817f1816 · Cited by 345
ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms
Ramage, J. K., De Herder, W. W., Delle Fave, G., Ferolla, P., Ferone, D., Ito, T., Ruszniewski, P., Sundin, A., Weber, W., Zheng-Pei, Z., et al. (2016) · Neuroendocrinology · doi:10.1159/000443166 · Cited by 328
Self-citationENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
O’Toole, D., Grossman, A., Gross, D., Delle Fave, G., Barkmanova, J., O’Connor, J., Pape, U.-F., & Plöckinger, U. (2009) · Neuroendocrinology · doi:10.1159/000225948 · Cited by 268
Self-citationCarcinoid Tumors of the Gastrointestinal Tract: Trends in Incidence in England Since 1971
Ellis, L., Shale, M. J., & Coleman, M. P. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.341 · Cited by 261
Epidemiology and survival in patients with carcinoid disease in the Netherlands
Quaedvlieg, P. F. H. J., Visser, O., Lamers, C. B. H. W., Janssen-Heijen, M. L. G., & Taal, B. G. (2001) · Annals of Oncology · doi:10.1023/a:1012272314550 · Cited by 260
Malignancies of the Appendix: Beyond Case Series Reports
McGory, M. L., Maggard, M. A., Kang, H., O'Connell, J. B., & Ko, C. Y. (2005) · Diseases of the Colon & Rectum · doi:10.1007/s10350-005-0196-4 · Cited by 258
Carcinoid tumour of the appendix
Goede, A. C., Caplin, M. E., & Winslet, M. C. (2003) · British Journal of Surgery · doi:10.1002/bjs.4375 · Cited by 238
The Epidemiology of Neuroendocrine Tumors in Taiwan: A Nation-Wide Cancer Registry-Based Study
Tsai, H.-J., Wu, C.-C., Tsai, C.-R., Lin, S.-F., Chen, L.-T., & Chang, J. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062487 · Cited by 163
Lepage, C., Bouvier, A.-M., Manfredi, S., Dancourt, V., & Faivre, J. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00854.x · Cited by 163
Benedix, F., Reimer, A., Gastinger, I., Mroczkowski, P., Lippert, H., & Kube, R. (2010) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2010.05.025 · Cited by 158
Arnold, R., Chen, Y.-J., Costa, F. P., Falconi, M., Gross, D., Grossman, A. B., Hyrdel, R., Kos‐Kudła, B., Salazar, R., & Plöckinger, U. (2009) · Neuroendocrinology · doi:10.1159/000225952 · Cited by 146
Self-citationCarcinoid tumors of the appendix: A population‐based study
Mullen, J. T., & Savarese, D. M. F. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21888 · Cited by 145
Survival From Malignant Digestive Endocrine Tumors in England and Wales: A Population-Based Study
Lepage, C., Rachet, B., & Coleman, M. P. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.006 · Cited by 124
Carcinoid Tumour of the Appendix: An Analysis of 1,485 Consecutive Emergency Appendectomies
Hof, K. H. I. ‘., van der Wal, H. C., Geert Kazemier, M., & Lange, J. F. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0545-4 · Cited by 119
The German NET-Registry: An Audit on the Diagnosis and Therapy of Neuroendocrine Tumors
Ploeckinger, U., Kloeppel, G., Wiedenmann, B., & Lohmann, R. (2009) · Neuroendocrinology · doi:10.1159/000242109 · Cited by 110
Neuroendocrine tumours (carcinoids) of the appendix
Stinner, B., & Rothmund, Μ. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.06.003 · Cited by 103
Analysis of 900 Appendiceal Carcinoid Tumors for a Proposed Predictive Staging System
Landry, C. S. (2008) · Archives of Surgery · doi:10.1001/archsurg.143.7.664 · Cited by 102
Volante, M., Daniele, L., Asioli, S., Cassoni, P., Comino, A., Coverlizza, S., Giuli, P. D., Fava, C., Manini, C., Berruti, A., et al. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318275d1d7 · Cited by 68
Neuroendocrine tumors of the appendix in children and adolescents
Boxberger, N., Redlich, A., Böger, C., et al. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24267 · Cited by 67
Groth, S. S., Virnig, B. A., Al‐Refaie, W. B., et al. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21764 · Cited by 66
Shapiro, R., Eldar, S. M., Sadot, E., et al. (2011) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2010.04.016 · Cited by 63
Niederle, M. B., & Niederle, B. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0002 · Cited by 60
Self-citationGenetic Differentiation of Appendiceal Tumor Malignancy
Modlin, I. M., Kidd, M. S., Latich, I., Zikusoka, M. N., Eick, G. N., Mane, S., & Camp, R. L. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000217617.06782.d5 · Cited by 56
Management and outcome of neuroendocrine tumours of the appendix—a two centre UK experience
Henderson, L. R., Fehily, C., Folaranmi, S. E., Kelsey, A. M., McPartland, J., Jawaid, W., Craigie, R., & Losty, P. D. (2014) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2014.05.019 · Cited by 42
Clinical value of right hemicolectomy for appendiceal carcinoids using pathologic criteria
Alexandraki, K., Grınıatsos, J., Bramis, K., et al. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03347081 · Cited by 39
Carcinoid Tumors of the Appendix: Are These Tumors Identifiable Prospectively on Preoperative CT?
Coursey, C. A., Nelson, R. C., Moreno, R. D., Dodd, L. G., Patel, M. B., & Vaslef, S. N. (2010) · The American Surgeon · doi:10.1177/000313481007600306 · Cited by 29
Carcinoid Tumours in the Gastrointestinal Tract — A Population-Based Study from Western Norway
Helland, S., Prøsch, A. M., & Viste, A. (2006) · Scandinavian Journal of Surgery · doi:10.1177/145749690609500305 · Cited by 23
Primary epithelial tumours of the appendix in a black population: A review of cases
Graham, R. P., Williams, N. P., & West, K. A. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1472 · Cited by 20
Crea, N., Pata, G., Betta, E. D., Titi, A., & Mittempergher, F. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0112-4 · Cited by 17
Cited by
Falconi, M., Eriksson, B., Kaltsas, G., Bartsch, D. K., Capdevila, J., Caplin, M., Kos-Kudla, B., Kwekkeboom, D., Rindi, G., Klöppel, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000443171 · Cited by 1,362
Self-citationPavel, M., O''Toole, D., Costa, F., Capdevila, J., Gross, D., Kianmanesh, R., Krenning, E., Knigge, U., Salazar, R., Pape, U.-F., et al. (2016) · Neuroendocrinology · doi:10.1159/000443167 · Cited by 1,041
Self-citationGarcia-Carbonero, R., Sorbye, H., Baudin, E., Raymond, E., Wiedenmann, B., Niederle, B., Sedlackova, E., Toumpanakis, C., Anlauf, M., Cwikla, J. B., et al. (2016) · Neuroendocrinology · doi:10.1159/000443172 · Cited by 611
Self-citationENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
Delle Fave, G., O''Toole, D., Sundin, A., Taal, B., Ferolla, P., Ramage, J. K., Ferone, D., Ito, T., Weber, W., Zheng-Pei, Z., et al. (2016) · Neuroendocrinology · doi:10.1159/000443168 · Cited by 495
Self-citationENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
Niederle, B., Pape, U.-F., Costa, F., Gross, D., Kelestimur, F., Knigge, U., Öberg, K., Pavel, M., Perren, A., Toumpanakis, C., et al. (2016) · Neuroendocrinology · doi:10.1159/000443170 · Cited by 474
Self-citation
Metadata
- Authors
- Pape, U.-F., Niederle, B., Costa, F., Gross, D., Kelestimur, F., Kianmanesh, R., Knigge, U., Öberg, K., Pavel, M., Perren, A., Toumpanakis, C., O''Connor, J., Krenning, E., Reed, N., O''Toole, D., & participants, A. O. V. C. C.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 103
- Issue
- 2
- Pages
- 144-152
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2229301063
- Cited by
- 302
- References
- 44
- FWCI
- 20.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.